Molecular Subtype
Microsatellite Stable Colorectal Carcinoma
CI-CAN-00008042Explore in graph →
16 active trials
- NCIt
- C173324
Loading cancer entity…
Molecular Subtype
CI-CAN-00008042Explore in graph →
Clinical trials
24 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (3)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06206096 | PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC | unknown | Phase 2 | 40 | Chinese PLA General HospitalOTHER | 1 | Apr 30, 2024 | clinicaltrials |
Data updated 22 days agoSource updated Apr 30, 2024source: clinicaltrials